Current trends in the structure - Activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist

Medicinal Research Reviews

Volumn 25, Issue 5, 2005, Pages 545-556

  Wilczynski, Andrzej M ^a   Joseph, Christine G ^a   Haskell Luevano, Carrie ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

AGRP; G protein coupled receptors; ICK domain; Melanocortin receptors; Structure activity relationship

Indexed keywords

AGOUTI RELATED PROTEIN; CYSTINE; G PROTEIN COUPLED RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR ANTAGONIST; NEUROPEPTIDE; UNCLASSIFIED DRUG;

DISULFIDE BOND; DRUG ANTAGONISM; MOLECULAR MODEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, CHEMICAL; PROTEINS; RECEPTORS, MELANOCORTIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 24144487679     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20037     Document Type: Review

References (38)

1. Chhajlani V, Muceniece R, Wikberg JE. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 1993;195(2):866-873.
2. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268(20):15174-15179.
3. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993;268(11):8246-8250.
4. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 1994;200(3):1214-1220.
5. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8(10): 1298-1308.
6. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993;90(19):8856-8860.
7. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278(5335):135-138.
8. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, WoychikRP, Wilkison WO, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994; 371(6500):799-802.
9. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL. Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 1997;11(5):593-602.
10. Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I. Inverse agonist activity of agouti and agouti-related protein. Peptides 2003;24(4):603-609.
11. Haskell-Luevano C, Monck EK. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 2001;99(1): 1-7.
12. Nijenhuis WA, Oosterom J, Adan RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 2001;15(1):164-171.
13. 2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett 1998; 428(1-2):59-62.
14. Yang YK, Thompson DA, Dickinson CJ, Wilken J, Barsh GS, Kent SB, Gantz I. Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol 1999;13(1):148-155.
15. Tota MR, Smith TS, Mao C, MacNeil T, Mosley RT, Van der Ploeg LH, Fong TM. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors. Biochemistry 1999;38(3): 897-904.
16. Haskell-Luevano C, Monck EK, Wan YP, Schentrup AM. The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor. Peptides 2000; 21(5):683-689.
17. Thirumoorthy R, Holder JR, Bauzo RM, Richards NG, Edison AS, Haskell-Luevano C. Novel agouti-related-protein-based melanocortin-1 receptor antagonist. J Med Chem 2001;44(24):4114-4124.
18. Sharov AA, Fessing M, Atoyan R, Sharova TY, Haskell-Luevano C, Weiner L, Brissette JL, Gilchrest BA, Botchkarev VA. Bone Morphogenetic Protein signaling controls hair pigmentation by means of cross-Talk with the Melanocortin Receptor-1 Pathway. Proc Natl Acad Sci USA 2005;102:93-98.
19. Jarosinski MD, Dodson SW, Harding BJ, Hale C, McElvain M, Zamborelli TJ, Lenz DM, Bennett BD, Marasco J, Baumgartner J, Liu C-F, Karbon EW. Design and synthesis of simplified AGRP(65-112) analogues: Protein-mimetics with affinity at the Melanocortin receptors. Peptides: The wave of the future; 2001 June 9-14; San Diego, CA. p A79. (Peptides: The wave of the future).
20. Joseph CG, Bauzo RM, Xiang ZM, Shaw AM, Millard WJ, Haskell-Luevano C. Elongation studies of the human agouti-related protein (AGRP) core decapeptide (Yc CRFFNAFC Y) results in antagonism at the mouse melanocortin-3 receptor. Peptides 2003;24(2):263-270.
21. McNulty JC, Thompson DA, Bolin KA, Wilken J, Barsh GS, Millhauser GL. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein. Biochemistry 2001;40(51):15520-15527.
22. Jackson PJ, McNulty JC, Yang YK, Thompson DA, Chai B, Gantz I, Barsh GS, Millhauser GL. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity. Biochemistry 2002;41(24):7565-7572.
23. Wilczynski A, Wang XS, Joseph CG, Xiang Z, Bauzo RM, Scott JW, Sorensen NB, Shaw AM, Millard WJ, Richards NG, Haskell-Luevano C. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. J Med Chem 2004;47(9):2194-2207.
24. Joseph CG, Wang XS, Scott JW, Bauzo RM, Xiang Z, Richards NG, Haskell-Luevano C. Stereochemical studies of the monocyclic Agouti-related Protein (103-122) arg-phe-phe residues: Conversion of a Melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist. J Med Chem 2004;47(27):6702-6710.
25. Wilczynski A, Wang Xiang S, Bauzo RM, Xiang Z, Shaw AM, Millard WJ, Richards NG, Edison AS, Haskell-Luevano C. Structural characterization and pharmacology of A potent (Cys101-119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist. J Med Chem 2004;47: 5662-5673.
26. Jackson PJ, Yu B, Hunrichs B, Thompson DA, Chai B, Gantz I, Millhauser GL. Chimeras of the Agouti-related protein: Insights into agonist and antagonist selectivity of melanocortin receptors. Peptides (in press).
27. Joseph CG, Wilczynski AM, Holder JR, Bauzo RM, Scott JW, Haskell-Luevano C. Chimeric NDP-MSH and MTII melanocortin peptides with Agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity. Peptides 2003;24:1899-1908.
28. Bures EJ, Hui JO, Young Y, Chow DT, Katta V, Rohde MF, Zeni L, Rosenfeld RD, Stark KL, Haniu M. Determination of disulfide structure in Agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry 1998;37(35):12172-12177.
29. Young Y, Zeni L, Rosenfeld RD, Stark KL, Rohde MF, Haniu M. Disulfide assignment of the C-terminal cysteine knot of Agouti-related protein (AGRP) by direct sequencing analysis. J Pept Res 1999;54(6): 514-521.
30. Perry WL, Nakamura T, Swing DA, Secrest L, Eagleson B, Hustad CM, Copeland NG, Jenkins NA. Coupled site-directed mutagenesis/transgenesis identifies important functional domains of the mouse agouti protein. Genetics 1996;144(1):255-264.
31. Bolin KA, Anderson DJ, Trulson JA, Thompson DA, Wilken J, Kent SB, Gantz I, Millhauser GL. NMR structure of a minimized human Agouti related protein prepared by total chemical synthesis. FEBS Lett 1999;451(2):125-131.
32. Yang YK, Dickinson CJ, Zeng Q, Li JY, Thompson DA, Gantz I. Contribution of melanocortin receptor exoloops to Agouti-related protein binding. J Biol Chem 1999;274(20):14100-14106.
33. Yang Y, Chen M, Lai Y, Gantz I, Yagmurlu A, Georgeson KE, Harmon CM. Molecular determination of Agouti-related protein binding to human melanocortin-4 receptor. Mol Pharmacol 2003;64(1):94-103.
34. Yang YK, Fong TM, Dickinson CJ, Mao C, Li JY, Tota MR, Mosley R, Van Der Ploeg LH, Gantz I. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000; 39(48):14900-14911.
35. Haskell-Luevano C, Cone RD, Monck EK, Wan YP. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: Identification of Agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 2001;40(20):6164-6179.
36. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000;289(5480):739-745.
37. Lu D, Väge DI, Cone RD. A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol Endo 1998;12(4):592-604.
38. Yang Y-K, Dickinson C, Haskell-Luevano C, Gantz I. Molecular basis for the interaction of [Nle4, DPhe7] melanocyte stimulating hormone with the human melanocortin-1 receptor (melanocyte a-MSH receptor). J Biol Chem 1997;272:23000-23010.